Learning Activity 4: Self Assessment, Evaluation, and Credit Application Form

Please note that to receive credit you must achieve a score of at least 80%.

Physicians/Physician Assistants: Certificate of Credit will be emailed within 4 weeks of successful completion of the activity.

Pharmacists: The information that you participated will be uploaded to CPE Monitor and you will be able to access your credits from the profile you set up with NABP. For more information, please visit http://www.nabp.net/.

Question Title

1. Approximately what percent of patients with a first episode of C. difficile infection will experience a recurrent episode?

10%

25%

40%

75%

Question Title

2. C. difficile infection recurrence is defined as a re-onset of symptoms plus:

Positive stool test for C. difficile.

Positive test for presence of toxin.

White blood cell count >10,000.

Either Positive stool test for C. difficile or positive test for presence of toxin.

Question Title

3. A 54-year-old man was successfully treated with metronidazole for an initial episode of C. difficile infection. After 3 weeks of terminating metronidazole treatment, the patient experiences a recurrent C. difficile infection. According to the SHEA/IDSA guidelines, the recommended treatment would be:

Metronidazole.

Vancomycin.

Rifaximin.

Fidaxomicin.

Question Title

4. What do the SHEA/IDSA guidelines recommend for treatment of multiple recurrences of C. difficile infection?

Metronidazole

Vancomycin pulse-dosing

Fidaxomicin

Metronidazole plus vancomycin

Question Title

5. Fecal microbiota transplantation (FMT) is recommended:

As prophylaxis against a first episode of C. difficile infection in high-risk patients.

For treatment of an initial episode of C. difficile infection.

For treatment of patients with multiple recurrences of C. difficile infection.

For all of the above.